Erratum to: Efficacy and safety of aprepitant for the prevention of chemotherapy-induced nausea and vomiting during the first cycle of moderately emetogenic chemotherapy in Korean patients with a broad range of tumor types (Supportive Care in Cancer, (2017), 25, 3, (801-809), 10.1007/s00520-016-3463-0)

Jeong Eun Kim; Joung Soon Jang; Jae Weon Kim; Sung Yong Lee; Chi Heum Cho; Myung Ah Lee; Do Jin Kim; Myung Ju Ahn; Kil Yeon Lee; Sun Jin Sym; Myong Choel Lim; Hun Jung; Cho Eun Kim; Kyung Wan Min

doi:10.1007/s00520-017-3608-9

Erratum to: Efficacy and safety of aprepitant for the prevention of chemotherapy-induced nausea and vomiting during the first cycle of moderately emetogenic chemotherapy in Korean patients with a broad range of tumor types (Supportive Care in Cancer, (2017), 25, 3, (801-809), 10.1007/s00520-016-3463-0)

Jeong Eun Kim, Joung Soon Jang, Jae Weon Kim, Sung Yong Lee, Chi Heum Cho, Myung Ah Lee, Do Jin Kim, Myung Ju Ahn, Kil Yeon Lee, Sun Jin Sym, Myong Choel Lim, Hun Jung, Cho Eun Kim, Kyung Wan Min

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Unfortunately, the original version of this article contained errors. The names of Sung Yong Lee and Cho Eun Kim were incorrectly captured and are now corrected in this article. Affiliation 12 is also corrected. The baseline demographics table (Table 2) incorrectly reported percentages calculated out of the total population in each chemotherapy group, instead of out of the total population (as with the rest of the table). Below are the correct percentages: (Table presented).

Original language	English
Pages (from-to)	1741
Number of pages	1
Journal	Supportive Care in Cancer
Volume	25
Issue number	5
DOIs	https://doi.org/10.1007/s00520-017-3608-9
Publication status	Published - 2017 May 1
Externally published	Yes

ASJC Scopus subject areas

Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00520-017-3608-9

Fingerprint

Dive into the research topics of 'Erratum to: Efficacy and safety of aprepitant for the prevention of chemotherapy-induced nausea and vomiting during the first cycle of moderately emetogenic chemotherapy in Korean patients with a broad range of tumor types (Supportive Care in Cancer, (2017), 25, 3, (801-809), 10.1007/s00520-016-3463-0)'. Together they form a unique fingerprint.

Cite this

Kim, J. E., Jang, J. S., Kim, J. W., Lee, S. Y., Cho, C. H., Lee, M. A., Kim, D. J., Ahn, M. J., Lee, K. Y., Sym, S. J., Lim, M. C., Jung, H., Kim, C. E., & Min, K. W. (2017). Erratum to: Efficacy and safety of aprepitant for the prevention of chemotherapy-induced nausea and vomiting during the first cycle of moderately emetogenic chemotherapy in Korean patients with a broad range of tumor types (Supportive Care in Cancer, (2017), 25, 3, (801-809), 10.1007/s00520-016-3463-0). Supportive Care in Cancer, 25(5), 1741. https://doi.org/10.1007/s00520-017-3608-9

Erratum to: Efficacy and safety of aprepitant for the prevention of chemotherapy-induced nausea and vomiting during the first cycle of moderately emetogenic chemotherapy in Korean patients with a broad range of tumor types (Supportive Care in Cancer, (2017), 25, 3, (801-809), 10.1007/s00520-016-3463-0). / Kim, Jeong Eun; Jang, Joung Soon; Kim, Jae Weon et al.
In: Supportive Care in Cancer, Vol. 25, No. 5, 01.05.2017, p. 1741.

Research output: Contribution to journal › Comment/debate › peer-review

Kim, JE, Jang, JS, Kim, JW, Lee, SY, Cho, CH, Lee, MA, Kim, DJ, Ahn, MJ, Lee, KY, Sym, SJ, Lim, MC, Jung, H, Kim, CE & Min, KW 2017, 'Erratum to: Efficacy and safety of aprepitant for the prevention of chemotherapy-induced nausea and vomiting during the first cycle of moderately emetogenic chemotherapy in Korean patients with a broad range of tumor types (Supportive Care in Cancer, (2017), 25, 3, (801-809), 10.1007/s00520-016-3463-0)', Supportive Care in Cancer, vol. 25, no. 5, pp. 1741. https://doi.org/10.1007/s00520-017-3608-9

Kim JE, Jang JS, Kim JW, Lee SY, Cho CH, Lee MA et al. Erratum to: Efficacy and safety of aprepitant for the prevention of chemotherapy-induced nausea and vomiting during the first cycle of moderately emetogenic chemotherapy in Korean patients with a broad range of tumor types (Supportive Care in Cancer, (2017), 25, 3, (801-809), 10.1007/s00520-016-3463-0). Supportive Care in Cancer. 2017 May 1;25(5):1741. doi: 10.1007/s00520-017-3608-9

Kim, Jeong Eun ; Jang, Joung Soon ; Kim, Jae Weon et al. / Erratum to : Efficacy and safety of aprepitant for the prevention of chemotherapy-induced nausea and vomiting during the first cycle of moderately emetogenic chemotherapy in Korean patients with a broad range of tumor types (Supportive Care in Cancer, (2017), 25, 3, (801-809), 10.1007/s00520-016-3463-0). In: Supportive Care in Cancer. 2017 ; Vol. 25, No. 5. pp. 1741.

@article{cfc40dd3a45d41459fca71e0b1b54b26,

title = "Erratum to: Efficacy and safety of aprepitant for the prevention of chemotherapy-induced nausea and vomiting during the first cycle of moderately emetogenic chemotherapy in Korean patients with a broad range of tumor types (Supportive Care in Cancer, (2017), 25, 3, (801-809), 10.1007/s00520-016-3463-0)",

abstract = "Unfortunately, the original version of this article contained errors. The names of Sung Yong Lee and Cho Eun Kim were incorrectly captured and are now corrected in this article. Affiliation 12 is also corrected. The baseline demographics table (Table 2) incorrectly reported percentages calculated out of the total population in each chemotherapy group, instead of out of the total population (as with the rest of the table). Below are the correct percentages: (Table presented).",

author = "Kim, {Jeong Eun} and Jang, {Joung Soon} and Kim, {Jae Weon} and Lee, {Sung Yong} and Cho, {Chi Heum} and Lee, {Myung Ah} and Kim, {Do Jin} and Ahn, {Myung Ju} and Lee, {Kil Yeon} and Sym, {Sun Jin} and Lim, {Myong Choel} and Hun Jung and Kim, {Cho Eun} and Min, {Kyung Wan}",

note = "Publisher Copyright: {\textcopyright} 2017, Springer-Verlag Berlin Heidelberg.",

year = "2017",

month = may,

day = "1",

doi = "10.1007/s00520-017-3608-9",

language = "English",

volume = "25",

pages = "1741",

journal = "Supportive Care in Cancer",

issn = "0941-4355",

publisher = "Springer Verlag",

number = "5",

}

TY - JOUR

T1 - Erratum to

T2 - Efficacy and safety of aprepitant for the prevention of chemotherapy-induced nausea and vomiting during the first cycle of moderately emetogenic chemotherapy in Korean patients with a broad range of tumor types (Supportive Care in Cancer, (2017), 25, 3, (801-809), 10.1007/s00520-016-3463-0)

AU - Kim, Jeong Eun

AU - Jang, Joung Soon

AU - Kim, Jae Weon

AU - Lee, Sung Yong

AU - Cho, Chi Heum

AU - Lee, Myung Ah

AU - Kim, Do Jin

AU - Ahn, Myung Ju

AU - Lee, Kil Yeon

AU - Sym, Sun Jin

AU - Lim, Myong Choel

AU - Jung, Hun

AU - Kim, Cho Eun

AU - Min, Kyung Wan

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Unfortunately, the original version of this article contained errors. The names of Sung Yong Lee and Cho Eun Kim were incorrectly captured and are now corrected in this article. Affiliation 12 is also corrected. The baseline demographics table (Table 2) incorrectly reported percentages calculated out of the total population in each chemotherapy group, instead of out of the total population (as with the rest of the table). Below are the correct percentages: (Table presented).

AB - Unfortunately, the original version of this article contained errors. The names of Sung Yong Lee and Cho Eun Kim were incorrectly captured and are now corrected in this article. Affiliation 12 is also corrected. The baseline demographics table (Table 2) incorrectly reported percentages calculated out of the total population in each chemotherapy group, instead of out of the total population (as with the rest of the table). Below are the correct percentages: (Table presented).

UR - http://www.scopus.com/inward/record.url?scp=85012891620&partnerID=8YFLogxK

U2 - 10.1007/s00520-017-3608-9

DO - 10.1007/s00520-017-3608-9

M3 - Comment/debate

C2 - 28197847

AN - SCOPUS:85012891620

SN - 0941-4355

VL - 25

SP - 1741

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

IS - 5

ER -